¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â ¼­¿ï¾Æ»êº´¿ø ¾Ï ½ÉÆ÷Áö¾ö : 2023-09-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â ¼­¿ï¾Æ»êº´¿ø ¾Ï ½ÉÆ÷Áö¾ö : 2023-09-01
±³À°ÀÏÀÚ : 2023-09-01
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : 2023³â ¼­¿ï¾Æ»êº´¿ø ¾Ï ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ÇãÁ¤ÀÎ
¿¬¶ôó : 02-3010-2653  

À̸ÞÀÏ : hji0929@amc.seoul.kr

±³À°Á¾·ù : ¹æ»ç¼±Á¾¾çÇаú

Âü¼®¿¹»óÀÎ : 700¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:00~09:05 °³È¸»ç ¼Û½Ã¿­(¼­¿ï¾Æ»êº´¿ø ¾Ïº´¿ø)

±âŸ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:05~09:10 Welcome Remark ¼Û½Ã¿­(¼­¿ï¾Æ»êº´¿ø ¾Ïº´¿ø)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:10~09:40 Moving Forward with Precision Oncology in Breast Cancer Prue Francis(Peter MacCallum Cancer Center)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:40~10:10 PARPi, ADCs, and Other Targets in Epithelial Ovarian Cancer Angeles Alvarez Secord(Duke Cancer Institute)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 10:10~10:40 Carbon-ion Radiotherapy; the Past, Present, and Furture Hitoshi Ishikawa(QST Hospital)

ÈÞ½Ä 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 10:40~10:55 Coffee Break ±èÅ¿ø(¼­¿ï¾Æ»êº´¿ø ¾Ïº´¿ø)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 10:55~11:25 Digital Innovation and Compliance in Precision Oncology ±è±ÔÇ¥(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 11:25~11:55 ÃÊ°Å´ë AI½Ã´ë ¿ì¸®ÀÇ ´ëÀÀÀü·«°ú ÀÇ·áºÐ¾ßÀÇ ¿µÇâ ÇÏÁ¤¿ì(³×À̹ö AI·¦)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 11:55~12:25 Oncology Future Market Trend : Will the new technologies and platforms be magic bullets? Á¤¼ö¿ë(IQVIA)

½Ä»ç 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 12:30~14:00 Luncheon Áö¿øÁØ(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 14:00~14:20 Advances of Bronchoscopic Techniques for the Diagnosis and Treatment of Early Stage Lung Cancer Áö¿øÁØ(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 14:20~14:40 Updates in Patient Selection and Oncological Outcome for Sublobar Resection in Early-stage NSCLC À±À籤(¼­¿ï¾Æ»êº´¿ø ÈäºÎ¿Ü°ú)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 14:40~15:00 Optimal Stereotactic Ablative Radiotherapy for Early-stage Lung Cancer ¼Û½Ã¿­(¼­¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

Åä·Ð 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 15:00~15:10 Q&A ¼Û½Ã¿­(¼­¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

ÈÞ½Ä 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 15:10~15:20 Coffee Break À±½Å±³(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 15:20~15:40 Perioperative Immunotherapy for NSCLC in Daily Practice, Experience of ASAN À±½Å±³(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 15:40~16:00 Essentials for Radiologic Tumor Assessment in lung Cancer Treated with Neoadjuvant Immuno-chemotherapy ÃÖÁÖ¾Ö(¼­¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 16:00~16:20 Pathologic Assessment of Lung Cancer Resection Specimens Following Neoadjuvant therapy ȲÈñ»ó(¼­¿ï¾Æ»êº´¿ø º´¸®°ú)

Åä·Ð 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 16:20~16:30 Q&A ȲÈñ»ó(¼­¿ï¾Æ»êº´¿ø º´¸®°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â ¼­¿ï¾Æ»êº´¿ø ¾Ï ½ÉÆ÷Áö¾ö : 2023-09-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â Áß¾Ó´ëÇб³º´¿ø ÅÂ¾Æ ½ÉÀåÃÊÀ½ÆÄ ¿¬¼Ó°­Á 12°­ (¾ç½É½Ç À¯Ãâ·Î º¯ÇüÀ» ÃÊ·¡ÇÏ´Â ½ÉÁúȯ Áø´Ü°ú Ä¡·á) : 2023-09-01
´ÙÀ½±Û 2023 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2023) - 9¿ù 1ÀÏ (2ÀÏÂ÷) : 2023-09-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20912 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 130 2024-05-28
20911 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 89 2024-05-28
20910 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 129 2024-05-28
20909 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 82 2024-05-28
20908 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 152 2024-05-28
20907 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 92 2024-05-28
20906 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 71 2024-05-28
20905 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 58 2024-05-28
20904 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 76 2024-05-28
20903 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 138 2024-05-28
20902 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 68 2024-05-28
20901 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 76 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 143 2024-05-28
20899 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 50 2024-05-28
20898 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 135 2024-05-28
21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷